ProShares Ultra Nasdaq Biotechnology (BIB)

88.39
Delayed Data
As of May 22
 +0.51 / +0.58%
Today’s Change
37.05
Today|||52-Week Range
94.87
+40.86%
Year-to-Date

Investment Objective

The investment seeks daily investment results that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index ®. The fund invests in securities and derivatives that ProShare Advisors believes, in combination, should have similar daily return characteristics as two times (2x) the daily return of the index. The index is a modified capitalization weighted index that includes securities of NASDAQ listed companies that are classified as either biotechnology or pharmaceutical according to the Industry Classification Benchmark ("ICB") which also meet other eligibility criteria determined by NASDAQ. The fund is non-diversified.

No recent news for ProShares Ultra Nasdaq Biotechnology.

Performance

1 month-0.19% 3 years+94.61%
3 months+15.79% 5 years+73.03%
1 year+129.36% Since inception+61.86%
Data through 05/23/2015

Quote Details

Previous close$87.88
Open day’s range87.60 – 88.90
Net asset value (NAV)88.36 (05/22/2015)
Daily volume452,100
Average volume (3 months)1,000,902
Data as of 4:00pm ET, 05/22/2015

Peer Comparisonvs. Trading-leveraged equity ETFs

 BIBCategory
Performance 5-yr return+73.03%+21.46%
Expense Gross exp ratio1.08%0.89%
Risk 5 year sharpe ratio1.44--
Net assets$811.6M$192.5M
Average market cap----
Average P/E----
Dividend / Share--0.20%

Competitors

SFLA iPath® Long Extended S&P 500® TR Index...
SSO ProShares Ultra S&P500
ROLA iPath® Long Extended Russell 1000® TR ...

Holdings

Top 5 Sectors
Portfolio weighting
Business service --
Consumer goods --
Consumer service --
Energy --
Financial service --
Top 10 Holdings
Portfolio weighting
-- 60.69%
-- 17.41%
-- 17.38%
-- 9.25%
-- 7.98%
BIIB Biogen5.67%
AMGN Amgen5.58%
CELG Celgene5.22%
GILD Gilead Sciences5.21%
-- 4.62%

To view my watchlist

Not a member yet?

Sign up now for a free account